Specifically, cannabidiol has also been shown to modulate the Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) pathway in glioma cells, promoting its activation in a dose-dependent manner [6]. The gene discussed is NFE2L2; the disease is central nervous system cancer.